|
|
|
18.08.25 - 13:33
|
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak (GlobeNewswire EN)
|
|
|
MONTREAL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX) announced today that it has filed and is in the process of mailing the management proxy circular (the “Circular”) and related materials in connection with its special meeting (the “Meeting”) of shareholders of the Company (the “Shareholders”) to be held in a hybrid format on Friday, September 12, 2025 at 10:00 a.m. (Eastern time) in connection with its previously announced transaction to be acquired by CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products....
|
|
|
|
|
09.07.25 - 13:33
|
Theratechnologies Reports Financial Results for the Second Quarter 2025 (GlobeNewswire EN)
|
|
|
MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today reported business highlights and financial results for the second quarter 2025, ended May 31, 2025. All figures are in U.S. dollars unless otherwise stated....
|
|
|
|
|
|
|
03.07.25 - 10:00
|
Theratechnologies: sharedealsPlus feiert Übernahme und bis zu +88% Rendite (Sharedeals)
|
|
|
Die nächste Übernahme, die nächste Party in der Community: Mit Theratechnologies ist ein weiterer sharedealsPlus-Tipp zum Übernahmeziel geworden. Mit dem gestern nachbörslich offiziell vermeldeten Buyout freuen sich unsere Mitglieder über bis zu +88% Rendite in weniger als drei Monaten. Das kanadische Biotechunternehmen, dessen Aktien an der US-Nasdaq handeln, wird von CB Biotechnology geschluckt – zu […]
The post Theratechnologies: sharedealsPlus feiert Übernahme und bis zu +88% Rendite first appeared on sharedeals.de....
|
|
|
03.07.25 - 04:12
|
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak (GlobeNewswire EN)
|
|
|
MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million....
|
|
|
|
|
|
|
|
|
16.04.25 - 00:03
|
Theratechnologies Provides Update on Sale Process (GlobeNewswire EN)
|
|
|
MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current circumstances, including the publicly announced proposal from Future Pak, the Board of Directors of the Company (the “Board”) has decided to further evaluate the potential sale of the Company through an open and non-exclusive process. In connection with this determination, the Board has authorized the special committee, consisting of independent and disinterested directors (the “Special Committee”), to oversee the process and make a recommendation to the full Board. To support this process, in addition to Barclays as financial advisor and Fasken as legal advisor, the Special Committee has also engaged Raymond James as independent financial advisor and Norton Rose Fulbright as independent legal advisor....
|
|
|
|
|
|
|
|
|
11.04.25 - 16:00
|
Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value (Business Wire)
|
|
|
WIXOM, Mich.--(BUSINESS WIRE)--Future Pak, LLC (“Future Pak”) today announced that it has submitted two formal proposals since January to acquire all outstanding shares of common stock of Theratechnologies Inc. (“Theratechnologies”) (NASDAQ: THTX). The most recent proposal, which remains open for consideration by Theratechnologies and its Board of Directors, offers a cash consideration of $3.51 to $4.50 per share.
The proposal represents a total enterprise value of up to $255 million, comprising:
$205 million in cash at closing, and
Up to $50 million in contingent value right (CVR) payments, including:
50% of the annual EGRIFTA® franchise gross profit (defined as net sales minus cost of goods, per U.S. GAAP) above $30 million annually for three years post-closing.
A $10 million one-time milestone payment if cumulative EGRIFTA gross profit exceeds $125 million over the same three-year period.
This offer implies a 164% to 238% premium to Theratechnologies' closing stock price of $1.33 as of April ...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
